13F
中

TENX TENAX THERAPEUTICS INC

2026Q1 · CUSIP 88032L605 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
79
Δ holders QoQ
+31
Breadth percentile
Top 9%
Whale holders
39
Δ whales
+17
Inst. holding value
$339M
New positions
34
Closed positions
3
Price momentum (1Q)
—
Put / Call
0/2

Breadth history (34 quarters)

2024Q2: Δ+2 · h=12 2024Q3: Δ+8 · h=20 2024Q4: Δ+2 · h=22 2025Q1: Δ+2 · h=24 2025Q2: Δ+3 · h=27 2025Q3: Δ+7 · h=34 2025Q4: Δ+14 · h=48 2026Q1: Δ+31 · h=79 2024Q2: holders=12 2024Q3: holders=20 2024Q4: holders=22 2025Q1: holders=24 2025Q2: holders=27 2025Q3: holders=34 2025Q4: holders=48 2026Q1: holders=79 -31 -15.5 +0 +15.5 +31 104783 24Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 9% — —

Options Sentiment

Put holders
0
QoQ: 0
Call holders
2
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.41
EPS YoY
-183.4%
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2025-03-31: EPS -0.28 2025-06-30: EPS -0.27 2025-09-30: EPS -0.40 2025-12-31: EPS -0.39 2026-03-31: EPS -0.35 -0.44 -0.22 0.00 20202021202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)